The Ohio State University Exercise Physiology Lab
Columbus, Ohio, 43210, United States
NCT Number: NCT02063165
The purpose of this study is to understand the role of a dietary oil to alter chronic disease risk factors in women who are at risk for heart disease and/or diabetes. The investigator's previous study showed that safflower oil reduced trunk fat mass in women with diabetes. The investigators believe safflower oil can also attenuate criteria of metabolic syndrome through reduction in trunk fat mass.
Looking for future studies?
Notify Me50 year–69 year
Female
Interventional
Not applicable
Columbus, Ohio, 43210, United States
The long-term goal is to develop effective and novel dietary and lifestyle strategies to reduce the progression of metabolic syndrome to chronic diseases such as coronary heart disease. The rationale for conducting this research study is that there are few effective strategies that target changes in body composition and metabolism as a means to attenuate metabolic syndrome. The investigators plan to test the central hypothesis and accomplish the overall objective of this research by pursuing the following three specific aims.
Specific Aim 1: Quantify the extent that linoleic acid reduces trunk adipose mass in women with metabolic syndrome.
Specific Aim 2: Measure changes in visceral adipose tissue
Specific Aim 3: Determine the time-dependent effect of linoleic acid to increase adiponectin levels.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 tsp per day (~10g of oil)
Time frame: Baseline and Week 16 (end of the study)
Time frame: Baseline through Week 16 (end of the study)
Time frame: Baseline through Week 16 (end of the study)
Mood questionnaires will be completed at each study visit
Time frame: Baseline through Week 16 (end of the Study)
Time frame: Baseline through Week 16 (end of the study)
Plasma and red blood cell fatty acid composition will be analyzed. Returned oil containers will be weighed to estimate oil consumption.
Time frame: Baseline through Week 16 (end of the study)
Serum glucose and insulin levels will be analyzed
Time frame: Baseline and Week 16 (end of the study)
Time frame: Baseline and Week 16 (end of study)
Time frame: Baseline through Week 16 (end of the study)
Adiponectin, leptin, and IL-6 will be analyzed
Ohio State University
Other
Healthy Oils for Women: Reducing Visceral Adipose Tissue in Women with Metabolic Syndrome (HOW Study)
Acronym: HOW
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04392284
Body Weight, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT03596983
Body Weight, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT06626867
Body Weight, Cardiovascular Diseases
Taipei, Taiwan
View Trial DetailsNCT04014686
Behavior, Cardiovascular Diseases
Omaha, Nebraska, United States
View Trial Details